DK0491415T3 - Orale svangerskabsforebyggende midler med lavt østrogen - Google Patents

Orale svangerskabsforebyggende midler med lavt østrogen

Info

Publication number: DK0491415T3
Authority: DK; Denmark
Prior art keywords: dosage units; equivalent; desogestrel; phase; progestogen
Prior art date: 1990-12-13

Application number

DK91203182.0T

Other languages

English (en)

Inventor

Engelbert Wilhelm Bergink

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1991-12-05

Publication date

1996-07-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0491415(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-12-05 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-07-08 Application granted granted Critical

1996-07-08 Publication of DK0491415T3 publication Critical patent/DK0491415T3/da

Links

239000000262 estrogen Substances 0.000 title abstract 4
229940011871 estrogen Drugs 0.000 title abstract 4
229940127234 oral contraceptive Drugs 0.000 title 1
239000003539 oral contraceptive agent Substances 0.000 title 1
RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 4
229960004976 desogestrel Drugs 0.000 abstract 4
239000000583 progesterone congener Substances 0.000 abstract 4
239000003433 contraceptive agent Substances 0.000 abstract 2
BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
230000002254 contraceptive effect Effects 0.000 abstract 1
230000001076 estrogenic effect Effects 0.000 abstract 1
229960002568 ethinylestradiol Drugs 0.000 abstract 1
230000000757 progestagenic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Cosmetics (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

DK91203182.0T 1990-12-13 1991-12-05 Orale svangerskabsforebyggende midler med lavt østrogen DK0491415T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90203309		1990-12-13

Publications (1)

Publication Number	Publication Date
DK0491415T3 true DK0491415T3 (da)	1996-07-08

Family

ID=8205195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91203182.0T DK0491415T3 (da)	1990-12-13	1991-12-05	Orale svangerskabsforebyggende midler med lavt østrogen

Country Status (18)

Country	Link
US (1)	US5262408A (da)
EP (1)	EP0491415B1 (da)
JP (1)	JPH04290828A (da)
KR (1)	KR100187316B1 (da)
CN (1)	CN1036835C (da)
AT (1)	ATE136218T1 (da)
AU (1)	AU645382B2 (da)
CA (1)	CA2057528C (da)
DE (1)	DE69118493T2 (da)
DK (1)	DK0491415T3 (da)
ES (1)	ES2087964T3 (da)
FI (1)	FI99083C (da)
GR (1)	GR3020179T3 (da)
IE (1)	IE71203B1 (da)
NO (1)	NO179234C (da)
NZ (1)	NZ240944A (da)
PT (1)	PT99782B (da)
ZA (1)	ZA919731B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5439913A (en)	1992-05-12	1995-08-08	Schering Aktiengesellschaft	Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) *	1993-02-19	1996-05-14	The Medical College Of Hampton Roads	Method of inhibiting fertilization
US6407082B1 (en)	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) *	1994-03-30	1995-10-05	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
IL115445A (en) *	1994-10-17	1999-08-17	Akzo Nobel Nv	Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5747480A (en) *	1996-05-08	1998-05-05	American Home Products Corporation	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
SI0917466T1 (en) *	1996-07-26	2005-02-28	Wyeth	Oral contraceptive
WO1998004267A1 (en) *	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
KR100518102B1 (ko) *	1996-07-26	2005-10-04	와이어쓰	프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트
US5858405A (en) *	1996-07-26	1999-01-12	American Home Products Corporation	Oral contraceptive
US6451778B1 (en)	1996-07-26	2002-09-17	Wyeth	Oral contraceptive
US6479475B1 (en)	1996-07-26	2002-11-12	Wyeth	Oral contraceptive
US6028064A (en)	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en)	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en)	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
US6214815B1 (en) *	1998-12-23	2001-04-10	Ortho-Mcneil Pharmaceuticals, Inc.	Triphasic oral contraceptive
WO2001030356A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US6855703B1 (en)	2000-03-10	2005-02-15	Endeavor Pharmaceuticals	Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en)	2000-03-10	2003-12-09	Endeavor Pharmaceuticals	Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) *	2000-03-10	2008-12-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) *	2003-07-23	2011-08-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and pharmaceutical formulations comprising the same
US20050113351A1 (en) *	2000-03-21	2005-05-26	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) *	2000-03-21	2004-09-09	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
NZ591627A (en)	2001-12-05	2012-09-28	Teva Womens Health Inc	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
EP1485103A1 (en) *	2002-03-11	2004-12-15	Janssen Pharmaceutica N.V.	Sulfatase inhibiting continuous progestogen contraceptive regimens
TW200403075A (en) *	2002-05-29	2004-03-01	Akzo Nobel Nv	Progestagenic dosage units
JP2004140323A (ja) *	2002-08-20	2004-05-13	Sharp Corp	半導体レーザ装置およびその製造方法
US6992075B2 (en) *	2003-04-04	2006-01-31	Barr Laboratories, Inc.	C(14) estrogenic compounds
CA2521471A1 (en) *	2003-04-11	2004-10-28	Barr Laboratories, Inc.	Methods of administering estrogens and progestins
DK1820494T3 (da) *	2003-06-13	2010-05-25	Skendi Finance Ltd	Mikropartikler bestående af estradiol og cholesterol
NZ545130A (en) *	2003-07-16	2009-03-31	Duramed Pharmaceuticals Inc	Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP1535618A1 (en) *	2003-11-26	2005-06-01	Schering Aktiengesellschaft	Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
MX2007004120A (es) *	2004-10-07	2007-06-15	Duramed Pharmaceuticals Inc	Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
US20070111975A1 (en)	2004-10-07	2007-05-17	Duramed Pharmaceuticals, Inc.	Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2431704A1 (de) *	1974-07-02	1976-01-22	Asche Ag	Stufenkombinationspraeparate per kontrazeption
NL8001593A (nl) *	1980-03-18	1981-10-16	Akzo Nv	Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4616006A (en) *	1983-09-26	1986-10-07	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4544554A (en) *	1983-09-26	1985-10-01	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4628051A (en) *	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
DK174724B1 (da) *	1986-07-15	2003-10-06	Wyeth Corp	Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet

1991
- 1991-12-04 IE IE422191A patent/IE71203B1/en not_active IP Right Cessation
- 1991-12-05 EP EP91203182A patent/EP0491415B1/en not_active Expired - Lifetime
- 1991-12-05 AT AT91203182T patent/ATE136218T1/de not_active IP Right Cessation
- 1991-12-05 DE DE69118493T patent/DE69118493T2/de not_active Expired - Fee Related
- 1991-12-05 ES ES91203182T patent/ES2087964T3/es not_active Expired - Lifetime
- 1991-12-05 DK DK91203182.0T patent/DK0491415T3/da active
- 1991-12-10 ZA ZA919731A patent/ZA919731B/xx unknown
- 1991-12-11 NZ NZ240944A patent/NZ240944A/xx not_active IP Right Cessation
- 1991-12-11 AU AU89647/91A patent/AU645382B2/en not_active Ceased
- 1991-12-12 CN CN91111089A patent/CN1036835C/zh not_active Expired - Fee Related
- 1991-12-12 KR KR1019910022726A patent/KR100187316B1/ko not_active Expired - Fee Related
- 1991-12-12 PT PT99782A patent/PT99782B/pt not_active IP Right Cessation
- 1991-12-12 US US07/806,966 patent/US5262408A/en not_active Expired - Lifetime
- 1991-12-12 FI FI915855A patent/FI99083C/fi not_active IP Right Cessation
- 1991-12-12 NO NO914900A patent/NO179234C/no unknown
- 1991-12-12 CA CA002057528A patent/CA2057528C/en not_active Expired - Fee Related
- 1991-12-13 JP JP3330885A patent/JPH04290828A/ja active Pending
1996
- 1996-06-07 GR GR960401541T patent/GR3020179T3/el unknown

Also Published As

Publication number	Publication date
ES2087964T3 (es)	1996-08-01
EP0491415A1 (en)	1992-06-24
US5262408A (en)	1993-11-16
JPH04290828A (ja)	1992-10-15
PT99782B (pt)	2001-05-31
NZ240944A (en)	1994-05-26
IE71203B1 (en)	1997-02-12
FI99083C (fi)	1997-10-10
KR920011517A (ko)	1992-07-24
NO179234B (no)	1996-05-28
PT99782A (pt)	1992-12-31
CN1036835C (zh)	1997-12-31
NO914900D0 (no)	1991-12-12
FI915855L (fi)	1992-06-14
IE914221A1 (en)	1992-06-17
NO179234C (no)	1996-09-04
ZA919731B (en)	1992-09-30
KR100187316B1 (ko)	1999-05-01
NO914900L (no)	1992-06-15
AU8964791A (en)	1992-06-18
FI915855A0 (fi)	1991-12-12
CN1062290A (zh)	1992-07-01
CA2057528A1 (en)	1992-06-14
GR3020179T3 (en)	1996-09-30
CA2057528C (en)	2003-02-04
AU645382B2 (en)	1994-01-13
DE69118493T2 (de)	1996-08-22
FI99083B (fi)	1997-06-30
EP0491415B1 (en)	1996-04-03
ATE136218T1 (de)	1996-04-15
DE69118493D1 (de)	1996-05-09

Publication	Publication Date	Title
DK0491415T3 (da)	1996-07-08	Orale svangerskabsforebyggende midler med lavt østrogen
AU645637B2 (en)	1994-01-20	Contraceptive regimen
NZ333750A (en)	2000-09-29	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
CA2356747A1 (en)	2000-07-06	Triphasic oral contraceptive
DE69710896D1 (en)	2002-04-11	Progestogen-anti-progestogen therapien
NZ333862A (en)	2000-08-25	Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
WO1997006807A3 (de)	1997-03-20	Kombinationspräparat zur kontrazeption, kits diese enthaltend und eine methode diese verwendend
ATE249222T1 (de)	2003-09-15	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
RU98114084A (ru)	2000-06-10	Способ и набор для контрацепции женских особей млекопитающих, состоящий из комбинации гестагена и эстрогена